| Literature DB >> 33243161 |
Fifonsi Adjidossi Gbeasor-Komlanvi1,2, Martin Kouame Tchankoni3, Akila Wimima Bakoubayi3, Matthieu Yaovi Lokossou3, Arnold Sadio4,3, Wendpouiré Ida Carine Zida-Compaore3, Mohaman Djibril4,5, Mofou Belo4,6, Amegnona Agbonon7, Didier Koumavi Ekouevi4,3.
Abstract
BACKGROUND: Assessing hospital mortality and its predictors is important as some of these can be prevented through appropriate interventions. Few studies have reported hospital mortality data among older adults in sub-Saharan Africa. The objective of this study was to assess the mortality and associated factors among hospitalized older adults in Togo.Entities:
Keywords: Ageing; Associated factors; Hospital; Mortality; Togo
Mesh:
Year: 2020 PMID: 33243161 PMCID: PMC7690011 DOI: 10.1186/s12877-020-01907-y
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Baseline socio-demographic characteristics of hospitalized older adults in Togo in 2019 (N = 650)
| Total | < 60 years | ≥ 60 years | ||
|---|---|---|---|---|
| Median (IQR) | 61 (55–70) | 55 (52–56) | 68 (63–72) | < 0.001* |
| 0.031** | ||||
| Male | 369 (56.8) | 169 (61.7) | 200 (53.2) | |
| Female | 281 (43.2) | 105 (38.3) | 176 (46.8) | |
| 0.593** | ||||
| Lomé | 379 (58.3) | 164 (59.9) | 215 (57.2) | |
| Other cities | 190 (29.2) | 77 (28.1) | 113 (30.0) | |
| MD | 81 (12.5) | 33 (12.0) | 48 (12.8) | |
| 0.008** | ||||
| Married/Living with a partner | 426 (65.5) | 196 (71.5) | 230 (61.2) | |
| Widow | 176 (27.1) | 45 (16.4) | 131 (34.8) | |
| Living alone | 45 (6.9) | 32 (11.7) | 13 (3.5) | |
| MD | 3 (0.5) | 1 (0.4) | 2 (0.5) | |
| < 0.001** | ||||
| No formal education | 178 (27.4) | 45 (16.4) | 133 (35.4) | |
| Primary school | 167 (25.7) | 66 (24.1) | 101 (26.9) | |
| Secondary school | 200 (30.8) | 128 (46.7) | 72 (19.1) | |
| University | 90 (13.8) | 29 (10.6) | 61 (16.2) | |
| MD | 15 (2.3) | 6 (2.2) | 9 (2.4) | |
| < 0.001** | ||||
| None | 33 (5.1) | 8 (2.9) | 25 (6.6) | |
| Financial aid | 190 (29.2) | 45 (16.4) | 145 (38.6) | |
| Pension fund | 109 (16.8) | 20 (7.3) | 89 (23.7) | |
| Income generating activity | 296 (45.5) | 189 (69.0) | 107 (28.4) | |
| MD | 22 (3.4) | 12 (4.4) | 10 (2.7) | |
| 0.648** | ||||
| < 53 | 146 (22.5) | 64 (23.4) | 82 (21.8) | |
| [53–150[ | 346 (53.2) | 141 (51.4) | 205 (54.5) | |
| ≥ 150 | 122 (18.8) | 55 (20.1) | 67 (17.8) | |
| MD | 36 (5.5) | 14 (5.1) | 22 (5.9) | |
| 0.930** | ||||
| No | 485 (74.6) | 201 (73.4) | 284 (75.5) | |
| Yes | 159 (24.5) | 68 (24.8) | 91 (24.2) | |
| MD | 6 (0.9) | 5 (1.8) | 1 (0.3) | |
| | 58 (8.8) | 28 (10.1) | 30 (7.8) | 0.393** |
| | 369 (56.0) | 169 (61.2) | 200 (52.2) | 0.070** |
| | 492 (74.7) | 203 (73.6) | 289 (75.5) | 0.832** |
| | 7 (1.1) | 3 (1.1) | 4 (1.0) | 0.996*** |
| | 47 (7.1) | 18 (6.5) | 29 (7.6) | 0.874** |
*Wilcoxon test; **Chi square test; ***Fisher test; aMultiple situation is possible
Baseline clinical characteristics of hospitalized older adults in Togo in 2019 (N = 650)
| Total | < 60 years | ≥ 60 years | ||
|---|---|---|---|---|
| 0.085* | ||||
| Median (IQR) | 17 (8–32) | 20 (10–34) | 16 (8–32) | |
| 0.178** | ||||
| Medical | 494 (76.0) | 201 (73.4) | 293 (77.9) | |
| Surgical | 156 (24.0) | 73 (26.6) | 83 (22.1) | |
| 0.739** | ||||
| Tertiary | 566 (87.1) | 240 (87.6) | 326 (86.7) | |
| Secondary | 84 (12.9) | 34 (12.4) | 50 (13.3) | |
| | 124 (19.1) | 37 (13.5) | 87 (23.1) | 0.002** |
| | 290 (44.6) | 105 (38.3) | 185 (49.2) | 0.006** |
| | 87 (13.4) | 33 (12.0) | 54 (14.4) | 0.238** |
| | 51 (7.8) | 16 (5.8) | 35 (9.3) | 0.104** |
| | 24 (3.7) | 6 (2.2) | 18 (4.8) | 0.511** |
| | < 0.001** | |||
| 0 | 262 (40.3) | 131 (47.8) | 131 (34.8) | |
| 1 | 254 (39.1) | 104 (38.0) | 150 (39.9) | |
| ≥ 2 | 134 (20.6) | 38 (14.2) | 95 (25.3) | |
| | 0.015** | |||
| None | 506 (77.8) | 226 (82.5) | 280 (74.5) | |
| Moderate/Severe | 144 (22.2) | 48 (17.5) | 96 (25.5) | |
| | 0.003** | |||
| No | 26 (4.0) | 18 (6.4) | 8 (2.1) | |
| Yes | 494 (76.0) | 204 (74.5) | 290 (77.1) | |
| MD | 130 (20.0) | 52 (19.0) | 78 (20.8) | |
| | 0.440** | |||
| No | 233 (35.8) | 98 (35.8) | 135 (35.9) | |
| Yes | 317 (48.8) | 145 (52.9) | 172 (45.7) | |
| MD | 100 (15.4) | 31 (11.3) | 69 (18.4) | |
| | 0.001** | |||
| Negative | 539 (83.0) | 211 (77.0) | 328 (87.2) | |
| Positive | 38 (5.8) | 26 (9.5) | 12 (3.2) | |
| MD | 73 (11.2) | 37 (13.5) | 36 (9.6) | |
| 111 (17.1) | 41 (15.0) | 70 (18.6) | 0.222** | |
| 91 (14.0) | 44 (16.1) | 47 (12.5) | 0.197** | |
| 81 (12.5) | 28 (10.2) | 53 (14.1) | 0.174** | |
| 75 (11.5) | 29 (10.6) | 46 (12.2) | 0.516** | |
| 66 (10.2) | 40 (14.6) | 26 (6.9) | 0.001** | |
| 53 (8.2) | 23 (8.4) | 30 (8.0) | 0.848** | |
| 49 (7.5) | 16 (5.8) | 33 (8.8) | 0.161** | |
| 31 (4.8) | 6 (2.2) | 25 (6.6) | 0.008** | |
MD Missing data, *Wilcoxon-Mann-Whitney; **Chi square test
aOther cardiovascular diseases: Cardiomyopathy, congestive heart failure, hypertension
bOther infections: Rhinopharyngitis, Influenza and Pneumopathy
Fig. 1Main diagnoses during hospitalization by proportion of deaths
Fig. 2Overall survival curve of hospitalized older adults in Lomé, Togo in 2019
Fig. 3Predictors of 3-month all-cause mortality using Cox proportional hazard regression multivariable model (N = 650)